1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow OLN324: new trials by email Literature Review of OLN324 trials Research Report on OLN324
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 Faricimab, OLN324 - Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration | Phase 1 | Completed | Ollin Biosciences, Inc. | 164 | 2025-02-12 | 2026-03-19 |
Puerto Rico (1) · United States (1)